Stockscreener 앱 받기
51.89
7.90%
-4.45
시간 외 거래:
52.25
0.36
+0.69%
전일 마감가:
$56.34
열려 있는:
$53.36
하루 거래량:
4.74M
Relative Volume:
3.08
시가총액:
$7.02B
수익:
$2.51B
순이익/손실:
$185.56M
주가수익비율:
38.72
EPS:
1.34
순현금흐름:
$517.59M
1주 성능:
-9.55%
1개월 성능:
-10.33%
6개월 성능:
-43.85%
1년 성능:
-28.56%
1일 변동 폭
$51.87
$53.75
1주일 범위
$51.87
$57.99
52주 변동 폭
$51.87
$94.93
Globus Medical Inc Stock (GMED) Company Profile
명칭
Globus Medical Inc
전화
610-930-1800
주소
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
GMED을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
51.89 | 7.77B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-19 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-30 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-02-10 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Needham | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-28 | 개시 | Wells Fargo | Overweight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-29 | 개시 | Loop Capital | Buy |
| 2021-02-18 | 재개 | Needham | Buy |
| 2020-12-08 | 개시 | Citigroup | Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2020-08-06 | 재확인 | Needham | Buy |
| 2020-08-06 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 개시 | Northland Capital | Market Perform |
| 2020-07-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 재확인 | Needham | Buy |
| 2020-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-12 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 재확인 | Needham | Buy |
| 2019-05-24 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 재확인 | Needham | Buy |
| 2019-02-28 | 업그레이드 | UBS | Neutral → Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 재확인 | Needham | Buy |
| 2018-04-04 | 업그레이드 | Needham | Hold → Buy |
모두보기
Globus Medical Inc 주식(GMED)의 최신 뉴스
Globus Medical CEO leaves for Dentsply Sirona corner office - MassDevice
Globus Medical Appoints Keith Pfeil as CEO - citybiz
Avantor and Globus Medical appoint new CEOs - The Business Journals
What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E - simplywall.st
Why Globus Medical (GMED) Shares Are Trading Lower Today - Yahoo Finance
Globus Medical stock holds steady as Needham maintains rating amid CEO change - Investing.com Canada
Globus Medical's Leadership Transition: A Strategic Catalyst for Long-Term Growth in the Medical Technology Sector - AInvest
Globus Medical's Leadership Transition and Growth Potential in a Post-Merger Landscape - AInvest
Globus Medical stock hits 52-week low at 53.54 USD By Investing.com - Investing.com Canada
Dentsply Sirona Hires Globus CEO Daniel Scavilla as Chief Exec - Medical Product Outsourcing
Impingement Syndrome Market Growing with Musculoskeletal - openPR.com
Globus Medical Announces New CEO and CFO - TipRanks
Dentsply Sirona Appoints Daniel Scavilla as President and CEO, Effective August 1, 2025 - Quiver Quantitative
Globus Medical sees Q2 revenue $745.3M, consensus $738.91M - TipRanks
Former Globus Medical CEO Takes Helm at Dentsply Sirona as Q2 Sales Hit $935M - Stock Titan
Globus Medical's Leadership Transition and Q2 Sales Performance: A Strategic Blueprint for Sustained Growth in Musculoskeletal Tech - AInvest
Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth - Investing.com
Globus Medical Expands Surgical Navigation Portfolio With Advanced DuraPro Oscillating System - MSN
GMED names new CEO & CFO after sudden resignation – compensation, details - Stock Titan
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results - GlobeNewswire
Globus Medical Shakes Up Leadership: New CEO Takes Helm as Q2 Sales Hit Record $745M, Up 18% - Stock Titan
What drives Globus Medical Inc. stock priceUnbelievable profit margins - PrintWeekIndia
What analysts say about Globus Medical Inc. stockFree Consultation - Autocar Professional
Globus Medical to Announce Q2 2025 Financial Results on August 7, Followed by Investor Call - MSN
Is Globus Medical Inc. a good long term investmentExplosive returns - Autocar Professional
Globus Medical Inc. Stock Analysis and ForecastFree Capital Efficiency Planning - Autocar Professional
GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain? - MSN
Carlsmed seeks up to $103M IPO haul to fuel spine surgery growth - MedTech Dive
RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED) - The Globe and Mail
Globus Medical Schedules Second Quarter Earnings Release and Conference Call | GMED Stock News - GuruFocus
Globus Medical, Inc. to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Nasdaq
Globus Medical Schedules Second Quarter Earnings Release and Conference Call - GlobeNewswire
Globus Medical Q2 Earnings Coming August 7: Key Focus on Musculoskeletal Tech Growth - Stock Titan
Globus Medical (GMED) Fell 19% in Q2 - MSN
Piper Sandler Maintained a Buy Rating on Globus Medical (GMED), Kept the PT Unchanged - Insider Monkey
Globus Medical expands Excelsius navigation capabilities - MassDevice
12 Best 52-Week Low Stocks to Buy According to Analysts - Insider Monkey
Bone Graft Harvester Market Future Business Opportunities - openPR.com
4 Analysts Assess Globus Medical: What You Need To Know - Benzinga
Globus Medical's DuraPro™ with Navigation: A Game-Changer in Spine Surgery? - AInvest
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue - The Manila Times
Globus Medical expands navigation capabilities with new DuraPro system By Investing.com - Investing.com Nigeria
Globus Medical expands navigation capabilities with new DuraPro system - Investing.com
Globus Medical Expands Excelsius Navigation Capabilities with Launch of DuraPro™ Oscillating System - Quiver Quantitative
Globus Medical Introduces DuraPro™ with Navigation, a - GlobeNewswire
Globus Medical's New DuraPro System Transforms $550M Surgical Navigation Market with Advanced Tissue Protection - Stock Titan
Globus Medical: Navigating Q2 Volatility to Seize Post-Merger Value - AInvest
Why Globus Medical Inc. stock attracts strong analyst attentionTop Analyst Picks - beatles.ru
PEEK Interbody Devices Market is projected to grow to US$ 4.6 - openPR.com
Robotic-assisted Surgery Systems Market Is Booming So Rapidly - openPR.com
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED) - The Globe and Mail
Globus Medical Inc (GMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):